Found 22 matching trials
Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant
PHASE1The primary objective of this study is to evaluate the pharmacokinetics (PK...
Fluvoxamine for Adults With Mild to Moderate COVID-19
PHASE2This clinical trial aims to determine if fluvoxamine, a selective serotonin...
Location
Asan Medical Center
Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464
PHASE1A two part, fixed-sequence, open-label crossover study to evaluate potentia...
Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD)
PHASE4This study will test the hypotheses that: 1. 12 weeks of Luvox-CR plus web-...
Location
The Rogers Center for Research & Training, Inc.
Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot
PHASE1Phenotyping is an approach largely used for the evaluation of the activity ...
Location
University Hospitals
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)
PHASE3The purpose of this study is to evaluate the effectiveness of repurposed me...
Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment
PHASE4Background. Depression is a highly frequent condition in the elderly, with ...
Location
Azienda Ospedaliera Universitaria Mater Domini, Università Magna Grecia
Risk of CYP2C19 Phenoconversion in Healthy Volunteers With Rapid, Normal, and Intermediate Predicted Metabolizers' Status
PHASE1CYP2C19 is responsible for the metabolism of approximately 10% of drugs cur...
Location
Geneva University Hospitals, HUG
ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)
PHASE3The purpose of this study is to evaluate the effectiveness of repurposed me...
Influence of Fluvoxamine on the Pharmacokinetics of BI 409306
PHASE1To investigate the influence of fluvoxamine on the pharmacokinetics of BI 4...
Location
Humanpharmakologisches Zentrum Biberach